Fanpeppu
4881.TPharmaceutical
Filed as FunPep Company Limited (2022-08–2026-08)
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Operating income | −¥1.6bn | −¥865m | −¥953m | −¥1.2bn | −¥745m | −¥565m |
| Ordinary income | −¥1.6bn | −¥858m | −¥898m | −¥1.2bn | −¥680m | −¥505m |
| Total assets | ¥2.0bn | ¥3.1bn | ¥2.4bn | ¥2.9bn | ¥3.4bn | ¥3.7bn |
| Net assets / equity | ¥1.5bn | ¥2.6bn | ¥2.4bn | ¥2.7bn | ¥3.2bn | ¥3.6bn |
| Operating cash flow | — | — | — | — | −¥887m | −¥414m |
| EPS (basic) | ¥-52.38 | ¥-30.95 | ¥-38.25 | ¥-59.9 | ¥-39.58 | ¥-40.37 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 62 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 159 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 62 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 150 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 60 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 38 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 141 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 27 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 39 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 26 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 114 figures · EDINET |
| 2021-01-01 → 2021-12-31 | AnnualAmended | 93 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 39 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 61 figures · EDINET |
6 more reports are still being processed.